ALX Oncology Holdings Inc. (ALXO) NASDAQ
2.03
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.03
+0(+0.00%)
Currency In USD
| Market Cap | 60.63M |
| Enterprise Value | 49.48M |
| P/E Ratio | -1.24 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.94 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.5 |
| Return On Equity | -1.24 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -99.39M |
| Net Income | -101.7M |
| Diluted EPS | -1.9 |
| Total Cash | 140.32M |
| Total Cash/Share | 2.59 |
| Total Debt | 5.22M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 7.21 |
| Book Value Per Share | 2.79 |
| 52-Week Change | 341.88 |
| 52-Week High | 2.66 |
| 52-Week Low | 0.4 |
| Moving Average 50 Days | 1.92 |
| Moving Average 200 Days | 1.57 |
| Average Volume | 921,901 |
| Shares Outstanding | 54.23M |
| % Held by Institutions | 54.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |